Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New developments in migraine prophylaxis.

Marcelo E Bigal¹, Abouch V Krymchantowski, Alan M Rapoport

¹Department of Neurology, Albert Einstein College of Medicine, New York, USA. mbigal@aecom.yu.edu

Expert Opinion on Pharmacotherapy

|April 2, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Novel optimization of multi-mechanistic approaches for the acute treatment of a migraine attack: A review.

Headache·2026

Same author

Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon.

Headache·2025

Same author

Optimising combined treatment for migraine and temporomandibular disorders (TMDs).

Cephalalgia : an international journal of headache·2025

Same author

Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.

CNS drugs·2024

Same author

Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints.

Expert review of neurotherapeutics·2024

Same author

Device profile of Nerivio for the acute and preventive treatment of episodic or chronic migraine in patients 12 years and older.

Expert review of medical devices·2023

Migraine prevention is evolving beyond traditional drugs. New options, including anticonvulsants and non-orthodox agents, show promise for patients with hyperexcitable brains.

Area of Science:

Neurology
Neuroscience

Background:

Migraine affects over 12% of US adults, causing disabling attacks.
Traditional prophylaxis (beta-blockers, antidepressants, calcium antagonists) offers insufficient relief for many.
Research suggests migraine may originate from a hyperexcitable brain.

Purpose of the Study:

To review and discuss emerging preventive strategies for migraine.
To highlight novel treatment options beyond established therapies.

Main Methods:

Review of recent clinical trials and research findings.
Discussion of anticonvulsant agents and non-orthodox substances.

Main Results:

Anticonvulsants represent a new perspective for migraine prophylaxis.

Related Experiment Videos

Several non-orthodox agents have demonstrated efficacy in clinical trials.

Conclusions:

New preventive options are available for migraine management.
Targeting brain hyperexcitability offers promising avenues for treatment.